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SUMMARY. Short-term (14 days) treatment with D-004, a lipid extract from Roystonea regia fruits, has
been shown to prevent testosterone (T)-induced prostate hyperplasia (PH) and increased oxidative stress
in rat prostate, but no study has documented if such effects persist after longer treatment. This study in-
vestigated the persistence of the effects of D-004 orally given for 60 days for preventing prostate enlarge-
ment and increase of oxidative markers in rats with T-induced PH. Rats were randomized into three
groups: a negative control and two T-injected that received orally vehicle (positive control) or D-004 (400
mg/kg/day), respectively. Prostate weights of positive controls significantly and markedly increased over
the time, while persistent and significant reductions of such increases were seen in D-004-treated rats. Al-
so, D-004 significantly reduced the T-induced increase of prostate conjugated diene generation and sul-
phydril groups concentrations, achieving a complete reduction from the day 30 after starting the treat-
ment. Concluding, the effects of oral treatment with D-004 (400 mg/kg/day) on T-induced prostate en-
largement and increased prostate oxidative markers persisted over 60 days of treatment. 
